Removing binding sites for an oncogene can slow cancer cell growth, researchers say

shutterstock oncogene

Cancer cell growth could be slowed down by removing binding sites for an oncogene, researchers from the University of Helsinki have discovered.

They have found a mechanism by which an oncogene commonly activated in cancer patients affects the growth rate of cells. In the future, the findings can help in developing new treatments that could prevent cancer genes from inducing tumor growth.

The researchers focusing on the effects of the MYC oncogene revealed new information about the factors that regulate the growth of cancer cells. MYC promotes the expression of genes that are important for cellular growth, and it is known to be overactive in more than half of all human cancers.

Therapeutic targeting

However, there are no drugs currently available for inhibiting MYC function because its protein structure is not well suited for therapeutic targeting.

An alternative option for preventing MYC activity would be to inhibit the function of the MYC target genes. In their recent study, the university researchers belonging to Academy of Finland’s Center of Excellence in Tumor Genetics Research have identified target genes of MYC that are responsible for its growth promoting effects.

Senior researcher Päivi Pihlajamaa, said: “In a healthy tissue, cell growth and proliferation are tightly controlled processes. During development of cancer, cells escape these control mechanisms and grow uncontrollably, explains senior researcher.”

Removing binding sites of the MYC oncogene slowed down cell growth

The researchers identified genomic binding sites of the MYC oncogene at the regulatory regions of its target genes and showed that removing these binding sites from DNA slowed down cell growth. The findings have recently been published in Nature Biotechnology.

“Our results show that very small changes to cellular DNA, such as modification of a single gene regulatory element, can have a significant effect on the proliferation rate of the cells,” confirms Pihlajamaa.

These findings may benefit many cancer patients in the future.

Pihlajamaa added: “Better understanding of the mechanisms that control cellular growth can help in identifying targets that can potentially be inhibited by new cancer drugs.”

Another main impact of this study comes from a novel method developed by the researchers. Importantly, it enables measuring the effects of changes in small DNA elements on cellular growth robustly and precisely.

Group leader and professor, Jussi Taipale, said: “The method is highly beneficial for future studies, since it can be used for investigating how various mutations affect proliferation and other cellular properties.

Genetic scissors

“The method is based on so called genetic scissors, namely the CRISPR-Cas9 system, that has recently become an important tool for biomedical research. The system has attracted a lot of attention since it enables genome editing with high efficiency and precision.”

The genome editing process, however, induces a DNA damage response and affects cellular growth. Thus, it is imperative that researchers can differentiate the effects of the mutation of interest from the ones caused by the genome editing process itself.

Taipale added: “Our method solves this problem by using an experimental strategy in which the cells that have undergone genome editing are directly compared to each other, and the unedited wild-type cells are discarded from the analysis.

“It is a powerful method that can have a major impact on elucidating the processes that control cellular growth in the future.”

Partnering 2030: The Biotech Perspective 2023

Download Inpart’s latest report revealing the priorities of out-licensers worldwide.

Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

This field is for validation purposes and should be left unchanged.